Skip to main content

Table 1 Characteristics of patients

From: Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1β/TNF

 

Osteoarthritis

Rheumatoid arthritis

number

17

17

age (yr)

68.8 ± 1.6

62.1 ± 3.0

sex (f/m)

14/3

13/4

C-reactive protein (mg/l)

9.4 ± 4.1

40.1 ± 14.6*

erythrocyte sedimentation rate (mm)

12.4 ± 2.6

41.5 ± 9.2*

medication

  

   prednisolone (%)

N.A.

88.0

   daily prednisolone (mg/d)

N.A.

4.3 ± 0.5

   methotrexate (%)

N.A.

35.3

   anti-TNF therapy (%)

N.A.

5.9

   leflunomide (%)

N.A.

29.4

   cyclosporin A (%)

N.A.

5.9

   peripherally acting opioidergic drugs (%)

41.2

35.3

   Non-steroidal antiinflammatory drugs (%)

70.6

64.7

  1. *P < 0.05 for the comparison vs. osteoarthritis. Abbreviations: N.A., not applicable.
  2. Data are given as means ± SEM, percentages in parentheses, and ranges in brackets